Fibrosarcomatous ("high-grade") dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance.
about
Dermatofibrosarcoma protuberans: 35 patients treated with Mohs micrographic surgery using paraffin sections.Recurrence case of rare scalp dermatofibrosarcoma protuberans: Two case reports of a wide radical excision, craniectomy bone involvement followed by cranioplasty and reconstruction.Clinical Features, Pathological Findings and Treatment of Recurrent Dermatofibrosarcoma Protuberans.Dermatofibrosarcoma protuberans with fibrosarcomatous transformation of the head and neck.Imatinib mesylate in advanced dermatofibrosarcoma protuberans: pooled analysis of two phase II clinical trials.Treatment of advanced dermatofibrosarcoma protuberans with imatinib mesylate with or without surgical resection.Dermatofibrosarcoma protuberans (DFSP): predictors of recurrence and the use of systemic therapy.Dermatofibrosarcoma protuberans (DFSP) successfully treated with sorafenib: case report.Current treatment options for dermatofibrosarcoma protuberans.Dermatofibrosarcoma protuberans: a clinicopathological study of 20 cases.Dermatofibrosarcoma protuberans: a study of clinical, pathologic, genetic, and therapeutic features in Korean patients.Transformed dermatofibrosarcoma protuberans: a clinicopathological study of eight casesCDKN2A/p16 Loss Implicates CDK4 as a Therapeutic Target in Imatinib-Resistant Dermatofibrosarcoma Protuberans.COL1A1-PDGFB fusion transcripts in fibrosarcomatous areas of six dermatofibrosarcomas protuberans.Fibrosarcomatous changes and expression of CD34+ and apolipoprotein-D in dermatofibrosarcoma protuberansLow-grade sarcomas with CD34-positive fibroblasts and low-grade myofibroblastic sarcomas.Target therapy of unresectable or metastatic dermatofibrosarcoma protuberans with imatinib mesylate: an analysis on 22 Chinese patients.Dermatofibrosarcoma protuberans--an update.A Case of Dermatofibrosarcoma Protuberans of the Trunk.Clinicopathological features of dermatofibrosarcoma protuberansTransformation of Dermatofibrosarcoma Protuberans into a Fibrosarcoma.Diagnostic Immunohistochemistry in Cutaneous Neoplasia: An UpdateFibrosarcomatous pigmented dermatofibrosarcoma protuberans: A case report with review of the literature.Risk factors for distant metastasis of dermatofibrosarcoma protuberans.Merkel cell carcinoma metastasis and dermatofibrosarcoma protuberans presenting as a collision tumour: a case report and review of the literature.A single-institutional review of 68 patients with dermatofibrosarcoma protuberans: wide re-excision after inadequate previous surgery results in a high rate of local controlStatus report on the management of dermatofibrosarcoma protuberans: is there a viable role for the use of imatinib mesylate? In which cases may it be therapeutically helpful and in which cases not?Management of dermatofibrosarcoma protuberans with fibrosarcomatous transformation: an evidence-based review of the literature.A study on the prognostic value of clinical and surgical features of dermatofibrosarcoma protuberans in Korean patients.Dermatofibrosarcoma protuberans: clinical diagnoses and treatment results of 260 cases in China.Fibrohistiocytic tumors and related neoplasms in children and adolescents.Advances in the systemic treatment of cutaneous sarcomas.Dermatofibrosarcoma protuberans in children: an update on the diagnosis and treatment.Fibrosarcoma: a review and update.Neoadjuvant treatment of Dermatofibrosarcoma Protuberans of pancreas with Imatinib: case report and systematic review of literature.A clinicopathologic review of a case series of dermatofibrosarcoma protuberans with fibrosarcomatous differentiation.Dermatofibrosarcoma protuberans of the vulva and groin: detection of COL1A1-PDGFB fusion transcripts by RT-PCR.Expression of COL1A1-PDGFB fusion transcripts in superficial adult fibrosarcoma suggests a close relationship to dermatofibrosarcoma protuberans.Myxoid cutaneous tumors: a review.Dermatofibrosarcoma Protuberans: A comprehensive review on the spectrum of clinico-radiological presentations.
P2860
Q33727183-44D00E18-209F-4992-89DC-3A6AB3BA65BAQ33771104-1059ED87-25E9-47B2-8C8C-A202F9834EA3Q33776781-552C5A6F-1D11-4362-8A3F-3AAA63056EC3Q34574045-4745DC14-FD6A-4CC8-9533-A33FD1BE0BFCQ34578454-16150269-B387-4CAD-BF58-0B075FDECEAFQ34620856-72D0A694-C91F-4980-8A20-B137A3251E95Q34623490-9988B539-85EC-42C5-BD89-35BDA7F85E71Q34650114-AED6FACB-548A-4E09-8001-807EF1488BE0Q34670080-EB68E26B-4184-4667-8AF7-3158EEC56489Q34995151-3B59517D-1273-4A97-A794-62E3A5D65759Q35086078-245F5B08-8064-450A-B8A9-2BBD74514E2BQ35588673-DB6C86EC-71D6-4267-859A-B82F79EA7674Q35691269-E0FFE5E0-CBB0-4A3A-9CEB-317199AC5356Q35869194-57EDBF1B-80AE-41EF-8540-4D19953C25BBQ35958157-798D7310-E63F-40A4-ACDC-D7EFA639C779Q36069780-E7B8BF51-9F66-4FB6-9F78-FC05456E664DQ36153797-89E03229-2B5B-4788-9279-060A22DF834EQ36309950-B4084CFD-28C8-4040-B0A8-095BEB315FDAQ36408802-0659989D-DD02-4744-B96F-E23294C36568Q36502469-0DA3DDF9-CBF6-41BD-B8F7-339FB92EA6BFQ36607123-F48F3A4F-E33F-4E46-8F16-AEDE4D7E19BAQ36752423-B4FA68DE-3801-4671-82A4-B193DB6AACF3Q36905306-E2337FA3-0735-48CB-A218-883C548AB24FQ37207911-885ADB1C-F12E-4E04-BDD8-3B59F4F886E4Q37304379-2C0C20FB-C7AB-419C-9158-DCCCFD65EADCQ37566914-68BA8748-E0F5-4E91-BCCE-D8150911741EQ37861555-760D8BE4-0185-460D-B465-E7E148D7CDB1Q37885434-FC98190E-5CF0-4FF8-AA3F-EBD68DA26637Q37905896-3D05E063-C531-4801-84DD-096CD5053DB7Q37911425-8C8E7E53-6F19-404C-8EA8-5446D01D16F7Q37993927-C6BB6B94-BB69-49DE-B3BC-6AC6C6C3BC55Q38000872-A84C0C17-14E2-49AB-BB22-10B9F7B72C3BQ38025163-B4736E27-C960-4730-ADF1-F6049D88DA01Q38165272-99803927-55BD-41C2-B82E-C694B3F80C3BQ38256161-BF15B26E-6D82-4527-B571-DA18430A5300Q38379910-A1EB4D53-6176-41C9-83C1-D9826A5AD373Q38453016-79DE3D0D-4F3F-4690-9912-2DE9B262A149Q38461502-9645BF2B-6A89-4C1C-8A97-6A4A4C5F1064Q38850921-D8F30997-1790-4371-AC4F-1A75E68F904FQ38983725-1C7C9913-02D0-4A28-A7DA-256CE3337037
P2860
Fibrosarcomatous ("high-grade") dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance.
description
1998 nî lūn-bûn
@nan
1998 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Fibrosarcomatous ("high-grade" ...... is on prognostic significance.
@ast
Fibrosarcomatous ("high-grade" ...... is on prognostic significance.
@en
Fibrosarcomatous
@nl
type
label
Fibrosarcomatous ("high-grade" ...... is on prognostic significance.
@ast
Fibrosarcomatous ("high-grade" ...... is on prognostic significance.
@en
Fibrosarcomatous
@nl
prefLabel
Fibrosarcomatous ("high-grade" ...... is on prognostic significance.
@ast
Fibrosarcomatous ("high-grade" ...... is on prognostic significance.
@en
Fibrosarcomatous
@nl
P2093
P1476
Fibrosarcomatous ("high-grade" ...... is on prognostic significance.
@en
P2093
P304
P356
10.1097/00000478-199805000-00009
P407
P577
1998-05-01T00:00:00Z